Clinical Study
Long-Term Efficacy of Postpartum Intravenous Iron Therapy
Table 3
Questionnaire data at 6 months post-partum.
| | Oral iron | Intravenous + oral iron | | | ( = 150) | ( = 75) |
| Median duration of 80 mg/d oral iron sulphate supplementation (days) (all patients) | 30 (46.8)0–180 | 46 (45.2)0–180 |
.02 | Women taking oral iron supplementation (%) | 120 (80%) | 36 (48%) |
.006 | Breast-feeding women (%) | 131 (87.3%) (mean 20.9 weeks) | 68 (90.7%) (mean 20.7 weeks) | .84 | Vegetarians (%) | 11 (7.4%) | 8 (10.8%) | .34 | Mean physical performance (scale 1–10) | 6.9 (1.9)2–10 | 7.2 (1.7)2–10 | .36 | Menstruation 6 months post-partum | | | | None | 42 (28.4%) | 28 (37.3%) | .29 | Yes | 106 (71.6%) | 47 (62.7%) |
|
|
Values are expressed as mean (SD) range, or numbers and percentages.
|